Literature DB >> 21411753

Drugs targeting epigenetic histone acetylation in vascular smooth muscle cells for restenosis and atherosclerosis.

Rama Natarajan.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21411753      PMCID: PMC3063770          DOI: 10.1161/ATVBAHA.111.222976

Source DB:  PubMed          Journal:  Arterioscler Thromb Vasc Biol        ISSN: 1079-5642            Impact factor:   8.311


× No keyword cloud information.
  18 in total

1.  The language of covalent histone modifications.

Authors:  B D Strahl; C D Allis
Journal:  Nature       Date:  2000-01-06       Impact factor: 49.962

Review 2.  Histone acetyltransferases.

Authors:  S Y Roth; J M Denu; C D Allis
Journal:  Annu Rev Biochem       Date:  2001       Impact factor: 23.643

3.  Control of SRF binding to CArG box chromatin regulates smooth muscle gene expression in vivo.

Authors:  Oliver G McDonald; Brian R Wamhoff; Mark H Hoofnagle; Gary K Owens
Journal:  J Clin Invest       Date:  2006-01       Impact factor: 14.808

4.  Histone deacetylase HDAC8 associates with smooth muscle alpha-actin and is essential for smooth muscle cell contractility.

Authors:  David Waltregny; Wendy Glénisson; Siv Ly Tran; Brian J North; Eric Verdin; Alain Colige; Vincent Castronovo
Journal:  FASEB J       Date:  2005-03-16       Impact factor: 5.191

Review 5.  Chromatin modifications and their function.

Authors:  Tony Kouzarides
Journal:  Cell       Date:  2007-02-23       Impact factor: 41.582

6.  A novel histone deacetylase inhibitor reduces abdominal aortic aneurysm formation in angiotensin II-infused apolipoprotein E-deficient mice.

Authors:  Antony Vinh; Tracey A Gaspari; Hong Bin Liu; Lovisha F Dousha; Robert E Widdop; Anthony E Dear
Journal:  J Vasc Res       Date:  2007-10-24       Impact factor: 1.934

7.  Modulation of smooth muscle gene expression by association of histone acetyltransferases and deacetylases with myocardin.

Authors:  Dongsun Cao; Zhigao Wang; Chun-Li Zhang; Jiyeon Oh; Weibing Xing; Shijie Li; James A Richardson; Da-Zhi Wang; Eric N Olson
Journal:  Mol Cell Biol       Date:  2005-01       Impact factor: 4.272

Review 8.  Epigenetic histone acetylation modifiers in vascular remodelling: new targets for therapy in cardiovascular disease.

Authors:  Douwe Pons; Florentine R de Vries; Peter J van den Elsen; Bastiaan T Heijmans; Paul H A Quax; J Wouter Jukema
Journal:  Eur Heart J       Date:  2009-01-15       Impact factor: 29.983

9.  Angiotensin II stimulates protein kinase D-dependent histone deacetylase 5 phosphorylation and nuclear export leading to vascular smooth muscle cell hypertrophy.

Authors:  Xiangbin Xu; Chang-Hoon Ha; Chelsea Wong; Weiye Wang; Angelika Hausser; Klaus Pfizenmaier; Eric N Olson; Timothy A McKinsey; Zheng-Gen Jin
Journal:  Arterioscler Thromb Vasc Biol       Date:  2007-09-06       Impact factor: 8.311

10.  Cooperation of SRC-1 and p300 with NF-kappaB and CREB in angiotensin II-induced IL-6 expression in vascular smooth muscle cells.

Authors:  Saurabh Sahar; Marpadga A Reddy; Cynthie Wong; Li Meng; Mei Wang; Rama Natarajan
Journal:  Arterioscler Thromb Vasc Biol       Date:  2007-05-10       Impact factor: 8.311

View more
  5 in total

Review 1.  Epigenetic targets for novel therapies of lung diseases.

Authors:  Brian S Comer; Mariam Ba; Cherie A Singer; William T Gerthoffer
Journal:  Pharmacol Ther       Date:  2014-11-15       Impact factor: 12.310

Review 2.  Vascular smooth muscle cells in atherosclerosis: time for a re-assessment.

Authors:  Mandy O J Grootaert; Martin R Bennett
Journal:  Cardiovasc Res       Date:  2021-09-28       Impact factor: 10.787

Review 3.  Epigenetic modifications and diabetic nephropathy.

Authors:  Marpadga A Reddy; Jung Tak Park; Rama Natarajan
Journal:  Kidney Res Clin Pract       Date:  2012-07-21

Review 4.  Epigenetic Targets for Oligonucleotide Therapies of Pulmonary Arterial Hypertension.

Authors:  William Gerthoffer
Journal:  Int J Mol Sci       Date:  2020-12-03       Impact factor: 5.923

5.  Cathepsin S Activity Controls Injury-Related Vascular Repair in Mice via the TLR2-Mediated p38MAPK and PI3K-Akt/p-HDAC6 Signaling Pathway.

Authors:  Hongxian Wu; Xian Wu Cheng; Lina Hu; Kyosuke Takeshita; Chen Hu; Qiuna Du; Xiang Li; Enbo Zhu; Zhe Huang; Maimaiti Yisireyili; Guangxian Zhao; Limei Piao; Aiko Inoue; Haiying Jiang; Yanna Lei; Xiaohong Zhang; Shaowen Liu; Qiuyan Dai; Masafumi Kuzuya; Guo-Ping Shi; Toyoaki Murohara
Journal:  Arterioscler Thromb Vasc Biol       Date:  2016-06-30       Impact factor: 8.311

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.